"von Willebrand Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor.
Descriptor ID |
D014841
|
MeSH Number(s) |
D12.776.124.125.920 D23.119.985
|
Concept/Terms |
von Willebrand Factor- von Willebrand Factor
- Factor VIIIR-Ag
- Factor VIIIR Ag
- Factor VIIIR-RCo
- Factor VIIIR RCo
- Ristocetin-Willebrand Factor
- Ristocetin Willebrand Factor
- von Willebrand Protein
- Factor VIII-Related Antigen
- Factor VIII Related Antigen
- Ristocetin Cofactor
|
Below are MeSH descriptors whose meaning is more general than "von Willebrand Factor".
Below are MeSH descriptors whose meaning is more specific than "von Willebrand Factor".
This graph shows the total number of publications written about "von Willebrand Factor" by people in this website by year, and whether "von Willebrand Factor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 4 | 5 |
1995 | 3 | 3 | 6 |
1996 | 1 | 3 | 4 |
1997 | 4 | 2 | 6 |
1998 | 6 | 4 | 10 |
1999 | 0 | 1 | 1 |
2000 | 3 | 1 | 4 |
2001 | 1 | 1 | 2 |
2002 | 4 | 2 | 6 |
2003 | 9 | 4 | 13 |
2004 | 8 | 4 | 12 |
2005 | 6 | 2 | 8 |
2006 | 4 | 5 | 9 |
2007 | 3 | 4 | 7 |
2008 | 6 | 1 | 7 |
2009 | 5 | 2 | 7 |
2010 | 5 | 3 | 8 |
2011 | 4 | 2 | 6 |
2012 | 3 | 0 | 3 |
2013 | 10 | 1 | 11 |
2014 | 7 | 0 | 7 |
2015 | 8 | 5 | 13 |
2016 | 2 | 4 | 6 |
2017 | 5 | 2 | 7 |
2018 | 6 | 2 | 8 |
2019 | 5 | 0 | 5 |
2020 | 1 | 3 | 4 |
2021 | 2 | 1 | 3 |
2022 | 2 | 4 | 6 |
2023 | 4 | 3 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "von Willebrand Factor" by people in Profiles.
-
Microvascular activation and exocytosis after exposure to the serum from mismatched recipients by using donor microvascular cultures. Transpl Immunol. 2024 02; 82:101963.
-
Initial von Willebrand factor antigen values in adolescent females predict future values. Haemophilia. 2023 Nov; 29(6):1547-1555.
-
Recombinant ADAMTS-13 Improves Survival of Mice Subjected to Endotoxemia. Int J Mol Sci. 2023 Jul 22; 24(14).
-
Force-induced biphasic regulation of VWF cleavage by ADAMTS13. Thromb Res. 2023 09; 229:99-106.
-
Heat-inactivated Factor B inhibits alternative pathway fluid-phase activation and convertase formation on endothelial cell-secreted ultra-large von Willebrand factor strings. Sci Rep. 2023 04 08; 13(1):5764.
-
Keeping it together. Blood. 2023 03 23; 141(12):1374-1376.
-
Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA). Thromb Res. 2023 05; 225:39-46.
-
Histone-stimulated platelet adhesion to mouse cremaster venules in vivo is dependent on von Willebrand factor. Microcirculation. 2022 Nov; 29(8):e12782.
-
Whole-exome sequencing of 14?389 individuals from the ESP and CHARGE consortia identifies novel rare variation associated with hemostatic factors. Hum Mol Genet. 2022 09 10; 31(18):3120-3132.
-
High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19. J Thromb Thrombolysis. 2022 Aug; 54(2):211-216.